Hallucinogen-Related Disorders

Hallucinogens Overview - Trippy Toxins Taxonomy

• Definition: Psychoactive agents causing profound alterations in perception (hallucinations, illusions), mood, and cognition. Effects are highly variable.
• Key Classes & Examples:
  • Indoleamines (Serotonergic):
    • LSD (Lysergic acid diethylamide) - potent, synthetic.
    • Psilocybin (from 'magic mushrooms') - natural.
    • DMT (Dimethyltryptamine) - natural/synthetic.
    • Mechanism: Primarily 5-HT2A receptor agonists.
  • Phenylethylamines:
    • Mescaline (from peyote cactus) - natural.
    • DOM (2,5-Dimethoxy-4-methylamphetamine) - synthetic.
    • MDMA (Ecstasy) - synthetic, also stimulant.
  • Dissociative Anesthetics:
    • PCP (Phencyclidine) - synthetic.
    • Ketamine - synthetic, medical use.
    • Mechanism: NMDA receptor antagonists.
  • Anticholinergics (Deliriants): Datura, Atropine (plant-derived). , and typical examples)

⭐ Examples: LSD, Psilocybin (mushrooms), Mescaline (peyote), DMT, PCP, Ketamine.

Mechanisms of Action - Brain's Serotonin Symphony

• Classical Hallucinogens (LSD, Psilocybin, Mescaline):
  • Primarily act as agonists at serotonin 5-HT2A receptors.
  • Also affect other 5-HT receptors (e.g., 5-HT1A, 5-HT2C).
  • Leads to ↑glutamate release in prefrontal cortex (PFC).

⭐ Classical hallucinogens (LSD, psilocybin, mescaline) primarily act as agonists at serotonin 5-HT2A receptors.

• Dissociative Anesthetics (PCP, Ketamine):
  • Non-competitive antagonists at NMDA glutamate receptors.
  • Block glutamate action, leading to dissociative effects.
  • May also interact with dopamine, opioid, and sigma receptors.
• Atypical Hallucinogens (e.g., Salvinorin A):
  • Potent and selective agonist at kappa-opioid receptors.
  • Unique mechanism, distinct from classical or dissociative types.

Clinical Features & Intoxication - Perceptual Kaleidoscope

• General Intoxication Features:

  • Perceptual Distortions: Vivid visual, auditory, tactile hallucinations; illusions; synesthesia (e.g., "seeing sounds"); distorted time/space perception.
  • Mood & Thought: Marked anxiety or depression, panic ("bad trip"), euphoria, paranoia, grandiosity, depersonalization, derealization, impaired judgment.
  • Somatic (Sympathomimetic): Mydriasis (dilated pupils), tachycardia, hypertension, hyperthermia, sweating, palpitations, tremors, incoordination, nausea.

• Classic Hallucinogens (e.g., LSD, Psilocybin, Mescaline):

  • Key: Predominantly perceptual changes, mood alteration.
  • Physical: Significant mydriasis, ↑HR, ↑BP.
  • "Good trip" (euphoria, mystical experiences) vs. "Bad trip" (intense anxiety, fear, psychosis-like state).

• Dissociative Anesthetics (e.g., Phencyclidine [PCP], Ketamine):

  • Key: Dissociation, analgesia, amnesia.
  • Behavioral: Agitation, aggression, impulsivity, unpredictable violence, bizarre behavior, psychosis.
  • Neurological: Nystagmus (vertical, horizontal, or rotatory - classic for PCP), ataxia, dysarthria, muscle rigidity, hyperacusis.
  • Severe: Seizures, coma, rhabdomyolysis, respiratory depression.

⭐ Phencyclidine (PCP) intoxication is uniquely associated with nystagmus (rotatory, horizontal, or vertical) and aggressive, violent behavior.

Management & Specific Syndromes - Navigating the Trip

• General Mgmt:
  • Supportive: Reassurance, "talk-down" technique, quiet, low-stimulus environment.
  • Agitation/Anxiety: Benzodiazepines (e.g., Lorazepam, Diazepam).
  • Severe Psychosis: If Benzodiazepines fail, consider antipsychotics (e.g., Haloperidol) cautiously.
• PCP Specifics:
  • Key: Manage hyperthermia, rhabdomyolysis, seizures.
  • Benzodiazepines for agitation/seizures. Avoid phenothiazines (↓seizure threshold).
• HPPD & Flashbacks:
  • HPPD: Persistent perceptual disturbances post-cessation.
  • Flashbacks: Episodic recurrences.
  • Tx: Reassurance; Benzodiazepines, SSRIs if distressing.

⭐ Hallucinogen Persisting Perception Disorder (HPPD) involves re-experiencing perceptual distortions after cessation of use, without current intoxication.

High‑Yield Points - ⚡ Biggest Takeaways

• Hallucinogens (LSD, psilocybin) cause perceptual distortions, visual hallucinations, and synesthesia.
• PCP intoxication features nystagmus (rotatory/vertical), aggression, ataxia, and muscle rigidity.
• Hallucinogen Persisting Perception Disorder (HPPD) involves recurrent flashbacks of perceptual disturbances.
• Management is mainly supportive care; benzodiazepines for agitation or PCP-induced symptoms.
• Classic hallucinogens (LSD) typically lack a significant withdrawal syndrome; PCP may have one.
• PCP can cause severe complications like hypertension, hyperthermia, and rhabdomyolysis.